ADM and migraine disorder: To clarify whether the canonical CGRP receptor mediates the response to adrenomedullin, further evaluation could be conducted to determine if a gepant, an antagonist of the CGRP receptor with very low affinity for AM receptors, is able to inhibit AM-induced migraine-like attacks.